Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ITFG2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | CYP4B1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | OAT | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | WASF1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | MRPS27 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | LCN8 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | POLDIP3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | MAP1LC3B2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | PLEKHS1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | CDK2AP1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |